In this context, researchers have recently developed cancer cell membrane-cloaked biomimetic nanoparticles for the TD of Signal Transducer and Activator of Transcription 3 (STAT3) siRNA to glioblastoma (GBM). This evidence concerns the gene STAT3 and glioblastoma.